IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...
Lactoferrin is an effective therapy for children with anemia of CKD. Both oral lactoferrin and intravenous iron dextran can effectively treat anemia of chronic kidney disease (CKD) in children, ...
A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in Blood ...
Following the Federal Trade Commission's approval to add iron dextran to the banned substances list under the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control ...
(ORLANDO, Dec. 6, 2025) Within a year of initiation, a multidisciplinary project to improve screening and treatment for iron deficiency in pregnancy resulted in a sixfold rise in screening rates for ...
Intravenous (IV) iron therapy is more effective than oral drugs for women with anemia and heavy periods, providing better cost value and quality of life.
IV iron dextran was the most cost-effective treatment, yielding 19.26 quality-adjusted life years at a cost of $157,500 vs 19.10 costing $152,900 for oral ferrous sulfate. HealthDay News — Intravenous ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results